First Patient Enrolled

Related by string. * fi rst . first . firsts . Firsts : FIRST LOOK AT . First Quarter Results . FIRST CALL . First Amendment protects / PATIENTS . PATIENT . pa tients . Patients : Breast Cancer Patients . terminally ill patients . Patient Safety . chronically ill patients / enrolling . enrolls . Enrolling . enrolled : GW enrolls . Enrolled Agents CPAs . QB Re Enrolls . visit www.aa.com enroll * *

Related by context. Frequent words. (Click for all words.) 83 Patient Enrollment 83 Meets Primary Endpoint 80 Completes Enrollment 79 Phase III Trial 78 Pivotal Trial 77 Initiates Phase II 77 Receives Orphan Drug Designation 77 Preclinical Data 77 Phase III Clinical Trial 77 Clinical Trial Results 77 Pivotal Phase III 76 Improves Survival 76 Pivotal Phase 75 Pivotal Study 75 Drug Candidate 75 Presents Positive 74 Initiate Phase 74 Study Demonstrates 74 FDA Accepts 74 Single Dose 73 II Clinical Trial 73 Cholesterol Drug 73 Pulmonary Arterial Hypertension 73 Inhaled Insulin 72 Prostate Cancer Patients 72 Commences Phase 72 Annual Meeting Date 72 Renal Cell Carcinoma 72 Metastatic Melanoma 72 Vertex Pharmaceuticals Announces 72 Heart Failure Patients 71 Announces FDA Clearance 71 Drug Shows Promise 71 Elderly Patients 71 RNAi Therapeutics 71 Generic Version 71 Announces Initiation 70 Patient Outcomes 70 Chronic Hepatitis C 70 Initiates Phase 70 FDA Clears 70 Clinical Study 70 Patients Treated 70 Develop Novel 69 Well Tolerated 69 Significantly Improves 69 MITTEILUNG UEBERMITTELT VON BUSINESS 69 THERAPEUTICS 69 Jumps Higher 69 Venous Thromboembolism 69 Patients Undergoing 69 Gastric Cancer 69 Upcoming Conferences 69 Reduces Risk 69 Golimumab 69 PET FROM 69 Acute Myocardial Infarction 69 Overactive Bladder 68 Acute Ischemic Stroke 68 Announces Presentation 68 Prostate Cancer Treatment 68 YOUR LOCAL ANIMAL SHELTER 68 Provides Shareholder 68 Pirfenidone 68 Tumor Growth 68 Positive Opinion 68 www.syntapharma.com 68 ACADIA Pharmaceuticals 68 Blood Thinner 68 Diabetic Macular Edema 68 Transcept Pharmaceuticals 68 Chronic Hepatitis B 68 Q2 Loss Narrows 68 Metastatic Colorectal Cancer 68 Monotherapy 68 Aliskiren 68 J Am Coll 68 Record Second Quarter 67 Diabetic Patients 67 Explore Strategic Alternatives 67 Q3 Loss Widens 67 Shows Promise 67 Q1 Loss Narrows 67 Significantly Reduces 67 PLEASE REFER TO 67 Record Third Quarter 67 Breast Cancer Treatment 67 Pediatric Patients 67 FY# Guidance 67 Significantly Reduced 67 Cognitive Impairment 67 Clinical Trials Update 67 Secures Financing 67 Postmenopausal Women 67 Patent Covering 67 Cervical Cancer Vaccine 67 Advanced Prostate Cancer 67 BY RYAN ERNST 67 Eculizumab 67 Kidney Failure 67 Q3 Loss Narrows

Back to home page